Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study
Adapt™ Monorail™ Carotid Stent System: A Postmarket Clinical Follow-up Study
Sponsor: Beth Israel Deaconess Medical Center
Listed as NCT01133327, this NA trial focuses on Carotid Artery Disease and Carotid Stenosis and remains completed. Sponsored by Beth Israel Deaconess Medical Center, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
- Boston Scientific Corporation
- CRO genae
- Massachusetts General Hospital
- Medidata Solutions
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Berlin, Germany , Bonheiden, Belgium , Dendermonde, Belgium , Dortmund, Germany , Heidelberg, Germany , Leipzig, Germany , Liège, Belgium , Munich, Germany , Toledo, Spain and 1 more location